SNOA: Prakiraan wutah bathi resik saben saham kanggo taun ngarep Sonoma Pharmaceuticals Inc.

Simbol lan logo merek Sonoma Pharmaceuticals (SNOA)

High competition in dermatology and reliance on distributors create revenue risks, as evidenced by shifting analyst estimates for EPS growth, where the metric stands at 0.00. Sonoma Pharmaceuticals (SNOA) maintains stability through transparent management focused on innovation. A flawless brand image and patient loyalty to hypochlorous acid-based products provide additional support.

Sonoma Pharma (SNOA): Prakiraan wutah bathi resik saben saham ing taun ngarep saka 04.07.2022 nganti 18.11.2026

Rincian metrik lan analitis perusahaan Sonoma Pharma (SNOA)

Analisis komprehensif perusahaan:sonomapharma.com, SNOA
Barang utama Sonoma Pharmaceuticals Inc.

This earnings per share growth forecast for Sonoma Pharmaceuticals (SNOA) reflects market expectations for EPS dynamics, measuring the growth rate of net income per share. The stability of this indicator confirms the sustainable expansion of Microcyn product lines into new markets, although tight monetary conditions may compress multiples, limiting final returns given a conservative pipeline.

Pesaing utama

Prakiraan wutah bathi resik saben saham kanggo taun ngarep Krystal Biotech|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep APGE (Apogee Therapeutics)|Prakiraan wutah bathi kanggo taun ngarep ARQT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep VCEL (Vericel)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Oruka Corp ORKA|Prakiraan wutah bathi kanggo taun ngarep Sanara MedTech Inc. SMTI|DBVT: Prakiraan wutah bathi saben saham kanggo taun ngarep|SLSN: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Journey Medical Corp. (DERM) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|FBRX: Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep empro.my|SLGL - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep AXIL|Prakiraan wutah bathi kanggo taun ngarep medicuspharma.com (MDCX)|Prakiraan wutah bathi kanggo taun ngarep VRCA (Verrica Pharmaceuticals Inc)|Dinamika bathi saben saham sing diarepake ing taun ngarep HOTH|BFRI: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep VYNE Therapeutics Inc.|QNRX: Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep AZTR|DRMA (Dermata Therapeutics, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep ELAB|Prakiraan wutah bathi kanggo taun ngarep RVNC